Shares of Progyny (NASDAQ:PGNY) surged in after-hours trading after the company reported earnings for its fourth quarter of Fiscal Year 2022. Earnings per share came in at $0.03, which beat analysts’ consensus estimate of $0.01 per share.
Sales increased by 68% year-over-year, with revenue hitting $214.3 million. This beat analysts’ expectations of $211.78 million.
Looking forward, management now expects revenue for Q1 2023 to be in the range of $245 million to $250 million. For reference, analysts were expecting $230.8 million in revenue.
Overall, Wall Street has a consensus price target of $43.25 on Progyny, implying 39.11% upside potential, as indicated by the graphic above.
